Medications

Nucleic acid drug iSN40 shows promise for osteoporosis treatment

Osteoporosis, characterized by an imbalance in bone remodeling, is a growing health concern worldwide. Previous research has highlighted the role of osteogenic CpG oligodeoxynucleotide (iSN40) in promoting osteoblast differentiation ...

page 2 from 40